Allon Therapeutics allontherapeutics.com


Public lists: Pharma Startups (4732)

Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizophrenia and cognitive impairment.The Company is listed on the Toronto Stock Exchange under the trading symbol "NPC" (Neuroprotection CompanyTM) and based in Vancouver.

Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. Allon has 3 Phase II human efficacy trials underway pursuing three large underserved markets: Alzheimer's disease, schizop...Show all

Company (Acquired)

Phone:

Fax:

1168 Hamilton Street
Suite 506
Vancouver, V6B 2S2
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Allon Therapeutics $2.5M Sep 10, 2004
Intarcia Therapeutics $1513.7M Apr 3, 2017
Celera Genomics $0M May 17, 2011
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Allon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Neuroprotection using nap-like and sal-like peptide mimetics Feb 18, 2010 Dec 04, 2012 Patent
Use of adnf polypeptides for treating peripheral neurotoxicity Oct 03, 2008 Mar 27, 2012 Patent